Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PLTR vs GSK✓SelectedUSD · GSKPLTR vs GSK performance historyLatest closeAs of+0.07%11/18
Stock and ETF performance explorer

PLTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-6.4%
GSK return
+7.0%
Excess return
-13.4%
Maximum drawdown
-44.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%-1.3%+1.4%-0.2%
7D-9.1%-3.1%-6.0%-9.7%
30D-19.3%-0.9%-18.4%-19.2%
3M-8.7%-4.2%-4.5%-9.2%
6M+15.9%-1.6%+17.5%+16.5%
YTD-11.9%+2.6%-14.5%-14.6%
1Y-6.4%+6.2%-12.6%-10.7%
All-6.4%+7.0%-13.4%-10.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling